Last update 29 Aug 2025
Shanghai University of Medicine and Health Sciences

Shanghai University of Medicine and Health Sciences

Education|2021|Shanghai Shi, China|
sumhs.admissions.cn

Overview

Tags

Neoplasms
Hemic and Lymphatic Diseases
Other Diseases
Small molecule drug
Radiopharmaceuticals and diagnostic agent
Bispecific antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms5
Endocrinology and Metabolic Disease2
Nervous System Diseases1
Hemic and Lymphatic Diseases1
Immune System Diseases1
Infectious Diseases1
Top 5 Drug TypeCount
Small molecule drug4
Radiopharmaceuticals and diagnostic agent1
Bispecific antibody1
Top 5 TargetCount
σ2 receptor(Sigma-2 receptor)1
CTNNB x EZH2 x VEGF-C x c-Myc1
Notch-1(Neurogenic locus notch homolog protein 1)1
FZD7 x PDL11
PKM2(Pyruvate kinase isozymes M1/M2)1

Related

6
Drugs associated with Shanghai University of Medicine and Health Sciences
Polyphyllin I(MUST)
Target
CTNNB x EZH2 x VEGF-C x c-Myc
Mechanism
CTNNB inhibitors [+3]
Active Org.
Qinghai Nationalities UniversityQinghai Nationalities University [+8]
Originator Org.
Chengdu University of Science & Technology
Active Indication
Lung Cancer [+4]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
Berbamine
Target
Notch-1
Mechanism
NOTCH1 inhibitors
Active Org.
Shanghai University of Medicine and Health SciencesShanghai University of Medicine and Health Sciences
Originator Org.
Shanghai University of Medicine and Health SciencesShanghai University of Medicine and Health Sciences
Active Indication
Sepsis
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
CN119638695
Patent Mining
Target
PKM2
Mechanism
PKM2 inhibitors
Active Org.
Shanghai University of Medicine and Health SciencesShanghai University of Medicine and Health Sciences
Originator Org.
Shanghai University of Medicine and Health SciencesShanghai University of Medicine and Health Sciences
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Shanghai University of Medicine and Health Sciences
Login to view more data
0 Patents (Medical) associated with Shanghai University of Medicine and Health Sciences
Login to view more data
100 Deals associated with Shanghai University of Medicine and Health Sciences
Login to view more data
100 Translational Medicine associated with Shanghai University of Medicine and Health Sciences
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 03 Aug 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
4
2
Preclinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Polyphyllin I(MUST)
 ( CTNNB x EZH2 x VEGF-C x c-Myc )		Hepatocellular Carcinoma
More
Preclinical
Berbamine
 ( Notch-1 )		Sepsis
More
Preclinical
WO2025055549
 ( σ2 receptor )Patent Mining		Nervous System Diseases
More
Discovery
CN119638695
 ( PKM2 )Patent Mining		Neoplasms
More
Discovery
US20230277699
 ( FAP )Patent Mining		Neoplasms
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free